Scientific Advisory Board

BioNet’s Scientific Advisory Board (SAB) comprises distinguished experts in vaccinology and infectious diseases, each bringing invaluable insights to the company’s mission of advancing vaccine development.

A Message from the Scientific Advisory Board

“As members of BioNet’s Scientific Advisory Board, we are honored to support the company’s mission of advancing vaccine innovation to address some of the world’s most pressing public health challenges. Our collective expertise in vaccinology, infectious diseases, and biotechnology enables us to provide strategic guidance and insights that drive BioNet’s groundbreaking research and development efforts. By working closely with BioNet’s leadership and research teams, we aim to accelerate the development of life-saving vaccines and enhance global access for a healthier and more resilient world.”

Stanley
Plotkin


Chairman, USA
Emeritus Prof. of Wistar Institute and U Pennsylvania, Philadelphia

Jacques Francois Martin


France
Former President The Vaccine Fund

Nicole
Guiso


France
Former Research Unit Head Institut Pasteur, Paris

Adam
Finn


United Kingdom
Prof. of Paediatrics, University of Bristol

Norbert
Pardi


USA
Asst. Prof. of the Perelman School of Medicine, U Pennsylvania, Philadelphia

Peter
Openshaw


United Kingdom
Prof. of Experimental Medicine at Imperial College, London (via Imperial Consultants)

William
Gruber


USA
Former SVP and Head of Pfizer Vaccine Clinical Research and Development